Physician profile
Pui Cheung
NPI 1699092213
$9,953.09
in general payments reported to CMS, 2019-2025
4 companies · $9,722 in 2025
The $9,722 reported for 2025 was more than what 95% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.97 · 2023: $41.15 · 2024: $89.80 · 2025: $9,722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,513 · Consulting Fee: $2,226 · Travel and Lodging: $1,187 · Food and Beverage: $789 · Education: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,512.50 |
| Consulting Fee | $2,225.80 |
| Travel and Lodging | $1,187.04 |
| Food and Beverage | $789.39 |
| Education | $138.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $6,180.43 | 2025 | Vafseo |
| Vantive US Healthcare LLC | $3,493.15 | 2025 | Renal - Pd, Renal - Chronic |
| Baxter Healthcare | $141.12 | 2022-2023 | Renal - Extraneal Solution |
| Travere Therapeutics, INC. | $138.39 | 2024-2025 | Filspari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pui Cheung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.